Heather L. Prichard, PhD Humacyte

Dr. Prichard has been with Humacyte since 2008 and brings over 15 years of scientific, pre-clinical, and clinical leadership experience in the fields of tissue engineering, extracellular matrix biology, and biological response to implantable biomaterials. At Humacyte, Dr. Prichard oversees the development, qualification, and clinical translation of the bioengineered blood vessel platform for hemodialysis. She currently leads the product development organization with overall responsibility for vascular research and development, pre-clinical testing, process development for commercial manufacturing, and analysis and quality control testing of manufactured vessels. Dr. Prichard also works closely with our key vascular surgeons and nephrologists to develop their roles as PI’s for Humacyte. Prior to joining Humacyte, she received her Ph.D. from Duke University in Biomedical Engineering with a focus on investigating the healing response to implantable tissue engineered biomaterials. Prior to her doctoral studies, Dr. Prichard completed her Bachelors of Chemical Engineering at the Georgia Institute of Technology and worked as a Research and Development Engineer for Proctor & Gamble.